Literature DB >> 17846779

[Botulinum toxin injection for production of ptosis].

R-L Merté1, I M Lanzl.   

Abstract

Selective muscles can be paralysed or weakened for a limited time period using botulinum toxin type A. The upper eyelid muscles can be a target, leading to a temporary protective ptosis. In this report we discuss indications for this application, describe how to perform the injection, and present results. The procedure is safe and effective.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17846779     DOI： 10.1007/s00347-007-1611-0

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


  11 in total

Review 1.  [Amniotic membrane transplantation for reconstruction of the ocular surface].

Authors:  F E Kruse; D Meller
Journal:  Ophthalmologe       Date:  2001-09       Impact factor: 1.059

2.  [Techniques for reconstruction of the corneal surface by transplantation of preserved human amniotic membrane].

Authors:  F E Kruse; K Rohrschneider; H E Völcker
Journal:  Ophthalmologe       Date:  1999-10       Impact factor: 1.059

3.  Temporary tarsorrhaphy induced with type A botulinum toxin.

Authors:  G E Wuebbolt; G Drummond
Journal:  Can J Ophthalmol       Date:  1991-12       Impact factor: 1.882

4.  Botulinum toxin A-induced protective ptosis in corneal disease.

Authors:  C M Kirkness; G G Adams; P N Dilly; J P Lee
Journal:  Ophthalmology       Date:  1988-04       Impact factor: 12.079

5.  Botulinum toxin A induced protective ptosis.

Authors:  G G Adams; C M Kirkness; J P Lee
Journal:  Eye (Lond)       Date:  1987       Impact factor: 3.775

6.  Persisting hypotropias following protective ptosis induced by botulinum neurotoxin.

Authors:  P L Heyworth; J P Lee
Journal:  Eye (Lond)       Date:  1994       Impact factor: 3.775

7.  Dose standardisation of botulinum toxin.

Authors:  A M Pickett; P Hambleton
Journal:  Lancet       Date:  1994-08-13       Impact factor: 79.321

8.  An evaluation of the safety and efficacy of botulinum toxin type A (BOTOX) when used to produce a protective ptosis.

Authors:  M F Ellis; M Daniell
Journal:  Clin Exp Ophthalmol       Date:  2001-12       Impact factor: 4.207

9.  [Protective ptosis by botulinum A toxin injection in corneal affectations].

Authors:  G C Gusek-Schneider; F Erbguth
Journal:  Klin Monbl Augenheilkd       Date:  1998-07       Impact factor: 0.700

10.  Rate of epithelialisation and re-operations in corneal ulcers treated with amniotic membrane transplantation combined with botulinum toxin-induced ptosis.

Authors:  Thomas Fuchsluger; Emre Tuerkeli; Henrike Westekemper; Joachim Esser; Klaus-Peter Steuhl; Daniel Meller
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-01-12       Impact factor: 3.535
View more
  3 in total

1.  [Botulinum toxin A induced protective ptosis for the treatment of recurrent epithelial defects in neurotrophic keratopathy].

Authors:  A Schilimow; B Wiechens
Journal:  Ophthalmologe       Date:  2017-08       Impact factor: 1.059

Review 2.  [Current and experimental treatment approaches for neurotrophic keratopathy].

Authors:  J Alder; S Mertsch; J Menzel-Severing; G Geerling
Journal:  Ophthalmologe       Date:  2019-02       Impact factor: 1.059

Review 3.  The use of botulinum toxin in head and face medicine: an interdisciplinary field.

Authors:  Rainer Laskawi
Journal:  Head Face Med       Date:  2008-03-10       Impact factor: 2.151
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.